Spain-based Catalyxx, a developer of bio-based chemicals, has secured a
€20 million grant from the European Union through RenewChem, a flagship project
selected by the Circular Bio-based Europe Joint Undertaking (CBE JU). The
funding will support the construction of Catalyxx's first commercial bio-based
chemicals plant in Europe, marking the company's transition from technology











